Global Genomics

Genomics Comprehensive Study by Application (Drug Discovery and Development, Diagnostics, Others), Services (NGS-based Services, Core Genomics Services, Biomarket Translation Services, Computational Services, Others), Technology (Sequencing, Microarray, PCR, Others), Product (Instruments/Systems/Software, Consumables & Reagents), End User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Others) Players and Region - Global Market Outlook to 2028

Genomics Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 14.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Genomics is defined as the branch of molecular biology that includes mapping genes and sequencing the DNA. It includes functional genomics, structural genomics, comparative genomics, pharmacogenomics, and others. The global genomics market is propelled by several key drivers, including advancements in genomic technologies, rising demand for personalized medicine, and increasing research activities in the fields of genetics and biotechnology. Additionally, government initiatives and funding for genomics research, along with growing awareness about the potential benefits of genomic sequencing in disease diagnosis and treatment, further stimulate market growth. However, the market faces restraints such as high costs associated with genomic testing, ethical concerns related to genetic privacy, and the complexity of interpreting vast genomic data. Despite these challenges, opportunities abound in the form of expanding applications of genomics in areas like agriculture, forensics, and drug discovery, as well as the emergence of innovative sequencing technologies and data analysis tools, which are expected to drive the market forward.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia-Pacific
UnitValue (USD Million)
Key Companies ProfiledThermo Fisher Scientific, Inc. (United States), Illumina, Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Eurofins Scientific (Germany), BGI Genomics (China), GE Healthcare (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (United States) and Myriad Genetics (United States)


According to AMA, the market for Genomics is expected to register a CAGR of 14.2% during the forecast period to 2028. This growth is primarily driven by Rising Government Funding and Growth in the Number of Genomics Projects and Decreasing Sequencing Costs and Growing Application Areas of Genomics such as Diagnostic Application and Precision Medicine and Entry of New Players.

Globally, a noticeable market trend is evident Growing R&D in the field of Genomics, and the Lower Cost of Deoxyribonucleic Acid Amplification using PCR The Biotechnology sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Thermo Fisher Scientific, Inc. (United States), Illumina, Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Eurofins Scientific (Germany), BGI Genomics (China), GE Healthcare (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (United States) and Myriad Genetics (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The genomics market is highly fragmented with several major players such as Thermo Fisher Scientific, Inc. (United States), Illumina, Inc. (United States), and QIAGEN N.V. (Netherlands), among others

Key Developments in the Market:
In January 2023, Moderna, Inc., a leading biotechnology firm specializing in messenger RNA (mRNA) therapeutics and vaccines, has recently finalized an agreement to acquire OriCiro Genomics K.K., a trailblazer in cell-free DNA synthesis and amplification technologies. This strategic partnership marks a significant step for Moderna in expanding its capabilities and expertise in the field of genomics.

Regulatory Insights:
The FDA regulates genetic tests and other genomic technologies that are used to diagnose, treat, or prevent diseases. The agency reviews and approves new genomic technologies, including gene therapies, and monitors their safety and efficacy.

Influencing Trend:
Growing R&D in the field of Genomics, and the Lower Cost of Deoxyribonucleic Acid Amplification using PCR

Market Growth Drivers:
Rising Government Funding and Growth in the Number of Genomics Projects and Decreasing Sequencing Costs and Growing Application Areas of Genomics such as Diagnostic Application and Precision Medicine and Entry of New Players

Challenges:
Problem Regarding Secure Storage of Large Volumes of Sequenced Data as well as Dearth of Trained Professionals

Restraints:
High Cost of Genomic Equipment

Opportunities:
Increasing Use of Genomics in Specialized/Personalized Medicine across the World

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Genomics Market
- Analysis about New Entrants in Genomics Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Genomics Study Sheds Light on
— The Genomics Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Genomics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Genomics industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Drug Discovery and Development
  • Diagnostics
  • Others
By Services
  • NGS-based Services
  • Core Genomics Services
  • Biomarket Translation Services
  • Computational Services
  • Others

By Technology
  • Sequencing
  • Microarray
  • PCR
  • Others

By Product
  • Instruments/Systems/Software
  • Consumables & Reagents

By End User
  • Hospitals
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Government Funding and Growth in the Number of Genomics Projects
      • 3.2.2. Decreasing Sequencing Costs and Growing Application Areas of Genomics such as Diagnostic Application and Precision Medicine and Entry of New Players
    • 3.3. Market Challenges
      • 3.3.1. Problem Regarding Secure Storage of Large Volumes of Sequenced Data as well as Dearth of Trained Professionals
    • 3.4. Market Trends
      • 3.4.1. Growing R&D in the field of Genomics, and the Lower Cost of Deoxyribonucleic Acid Amplification using PCR
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Genomics, by Application, Services, Technology, Product , End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Genomics (Value)
      • 5.2.1. Global Genomics by: Application (Value)
        • 5.2.1.1. Drug Discovery and Development
        • 5.2.1.2. Diagnostics
        • 5.2.1.3. Others
      • 5.2.2. Global Genomics by: Services (Value)
        • 5.2.2.1. NGS-based Services
        • 5.2.2.2. Core Genomics Services
        • 5.2.2.3. Biomarket Translation Services
        • 5.2.2.4. Computational Services
        • 5.2.2.5. Others
      • 5.2.3. Global Genomics by: Technology (Value)
        • 5.2.3.1. Sequencing
        • 5.2.3.2. Microarray
        • 5.2.3.3. PCR
        • 5.2.3.4. Others
      • 5.2.4. Global Genomics by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Academic and Research Institutes
        • 5.2.4.3. Pharmaceutical and Biotechnology Companies
        • 5.2.4.4. Others
      • 5.2.5. Global Genomics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Genomics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Illumina, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. QIAGEN N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agilent Technologies, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eurofins Scientific (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BGI Genomics (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GE Healthcare (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pacific Biosciences of California, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Myriad Genetics (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Genomics Sale, by Application, Services, Technology, Product , End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Genomics (Value)
      • 7.2.1. Global Genomics by: Application (Value)
        • 7.2.1.1. Drug Discovery and Development
        • 7.2.1.2. Diagnostics
        • 7.2.1.3. Others
      • 7.2.2. Global Genomics by: Services (Value)
        • 7.2.2.1. NGS-based Services
        • 7.2.2.2. Core Genomics Services
        • 7.2.2.3. Biomarket Translation Services
        • 7.2.2.4. Computational Services
        • 7.2.2.5. Others
      • 7.2.3. Global Genomics by: Technology (Value)
        • 7.2.3.1. Sequencing
        • 7.2.3.2. Microarray
        • 7.2.3.3. PCR
        • 7.2.3.4. Others
      • 7.2.4. Global Genomics by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Academic and Research Institutes
        • 7.2.4.3. Pharmaceutical and Biotechnology Companies
        • 7.2.4.4. Others
      • 7.2.5. Global Genomics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Genomics: by Application(USD Million)
  • Table 2. Genomics Drug Discovery and Development , by Region USD Million (2017-2022)
  • Table 3. Genomics Diagnostics , by Region USD Million (2017-2022)
  • Table 4. Genomics Others , by Region USD Million (2017-2022)
  • Table 5. Genomics: by Services(USD Million)
  • Table 6. Genomics NGS-based Services , by Region USD Million (2017-2022)
  • Table 7. Genomics Core Genomics Services , by Region USD Million (2017-2022)
  • Table 8. Genomics Biomarket Translation Services , by Region USD Million (2017-2022)
  • Table 9. Genomics Computational Services , by Region USD Million (2017-2022)
  • Table 10. Genomics Others , by Region USD Million (2017-2022)
  • Table 11. Genomics: by Technology(USD Million)
  • Table 12. Genomics Sequencing , by Region USD Million (2017-2022)
  • Table 13. Genomics Microarray , by Region USD Million (2017-2022)
  • Table 14. Genomics PCR , by Region USD Million (2017-2022)
  • Table 15. Genomics Others , by Region USD Million (2017-2022)
  • Table 16. Genomics: by End User(USD Million)
  • Table 17. Genomics Hospitals , by Region USD Million (2017-2022)
  • Table 18. Genomics Academic and Research Institutes , by Region USD Million (2017-2022)
  • Table 19. Genomics Pharmaceutical and Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 20. Genomics Others , by Region USD Million (2017-2022)
  • Table 21. South America Genomics, by Country USD Million (2017-2022)
  • Table 22. South America Genomics, by Application USD Million (2017-2022)
  • Table 23. South America Genomics, by Services USD Million (2017-2022)
  • Table 24. South America Genomics, by Technology USD Million (2017-2022)
  • Table 25. South America Genomics, by Product USD Million (2017-2022)
  • Table 26. South America Genomics, by End User USD Million (2017-2022)
  • Table 27. Brazil Genomics, by Application USD Million (2017-2022)
  • Table 28. Brazil Genomics, by Services USD Million (2017-2022)
  • Table 29. Brazil Genomics, by Technology USD Million (2017-2022)
  • Table 30. Brazil Genomics, by Product USD Million (2017-2022)
  • Table 31. Brazil Genomics, by End User USD Million (2017-2022)
  • Table 32. Argentina Genomics, by Application USD Million (2017-2022)
  • Table 33. Argentina Genomics, by Services USD Million (2017-2022)
  • Table 34. Argentina Genomics, by Technology USD Million (2017-2022)
  • Table 35. Argentina Genomics, by Product USD Million (2017-2022)
  • Table 36. Argentina Genomics, by End User USD Million (2017-2022)
  • Table 37. Rest of South America Genomics, by Application USD Million (2017-2022)
  • Table 38. Rest of South America Genomics, by Services USD Million (2017-2022)
  • Table 39. Rest of South America Genomics, by Technology USD Million (2017-2022)
  • Table 40. Rest of South America Genomics, by Product USD Million (2017-2022)
  • Table 41. Rest of South America Genomics, by End User USD Million (2017-2022)
  • Table 42. Asia Pacific Genomics, by Country USD Million (2017-2022)
  • Table 43. Asia Pacific Genomics, by Application USD Million (2017-2022)
  • Table 44. Asia Pacific Genomics, by Services USD Million (2017-2022)
  • Table 45. Asia Pacific Genomics, by Technology USD Million (2017-2022)
  • Table 46. Asia Pacific Genomics, by Product USD Million (2017-2022)
  • Table 47. Asia Pacific Genomics, by End User USD Million (2017-2022)
  • Table 48. China Genomics, by Application USD Million (2017-2022)
  • Table 49. China Genomics, by Services USD Million (2017-2022)
  • Table 50. China Genomics, by Technology USD Million (2017-2022)
  • Table 51. China Genomics, by Product USD Million (2017-2022)
  • Table 52. China Genomics, by End User USD Million (2017-2022)
  • Table 53. Japan Genomics, by Application USD Million (2017-2022)
  • Table 54. Japan Genomics, by Services USD Million (2017-2022)
  • Table 55. Japan Genomics, by Technology USD Million (2017-2022)
  • Table 56. Japan Genomics, by Product USD Million (2017-2022)
  • Table 57. Japan Genomics, by End User USD Million (2017-2022)
  • Table 58. India Genomics, by Application USD Million (2017-2022)
  • Table 59. India Genomics, by Services USD Million (2017-2022)
  • Table 60. India Genomics, by Technology USD Million (2017-2022)
  • Table 61. India Genomics, by Product USD Million (2017-2022)
  • Table 62. India Genomics, by End User USD Million (2017-2022)
  • Table 63. South Korea Genomics, by Application USD Million (2017-2022)
  • Table 64. South Korea Genomics, by Services USD Million (2017-2022)
  • Table 65. South Korea Genomics, by Technology USD Million (2017-2022)
  • Table 66. South Korea Genomics, by Product USD Million (2017-2022)
  • Table 67. South Korea Genomics, by End User USD Million (2017-2022)
  • Table 68. Taiwan Genomics, by Application USD Million (2017-2022)
  • Table 69. Taiwan Genomics, by Services USD Million (2017-2022)
  • Table 70. Taiwan Genomics, by Technology USD Million (2017-2022)
  • Table 71. Taiwan Genomics, by Product USD Million (2017-2022)
  • Table 72. Taiwan Genomics, by End User USD Million (2017-2022)
  • Table 73. Australia Genomics, by Application USD Million (2017-2022)
  • Table 74. Australia Genomics, by Services USD Million (2017-2022)
  • Table 75. Australia Genomics, by Technology USD Million (2017-2022)
  • Table 76. Australia Genomics, by Product USD Million (2017-2022)
  • Table 77. Australia Genomics, by End User USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Genomics, by Application USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Genomics, by Services USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Genomics, by Technology USD Million (2017-2022)
  • Table 81. Rest of Asia-Pacific Genomics, by Product USD Million (2017-2022)
  • Table 82. Rest of Asia-Pacific Genomics, by End User USD Million (2017-2022)
  • Table 83. Europe Genomics, by Country USD Million (2017-2022)
  • Table 84. Europe Genomics, by Application USD Million (2017-2022)
  • Table 85. Europe Genomics, by Services USD Million (2017-2022)
  • Table 86. Europe Genomics, by Technology USD Million (2017-2022)
  • Table 87. Europe Genomics, by Product USD Million (2017-2022)
  • Table 88. Europe Genomics, by End User USD Million (2017-2022)
  • Table 89. Germany Genomics, by Application USD Million (2017-2022)
  • Table 90. Germany Genomics, by Services USD Million (2017-2022)
  • Table 91. Germany Genomics, by Technology USD Million (2017-2022)
  • Table 92. Germany Genomics, by Product USD Million (2017-2022)
  • Table 93. Germany Genomics, by End User USD Million (2017-2022)
  • Table 94. France Genomics, by Application USD Million (2017-2022)
  • Table 95. France Genomics, by Services USD Million (2017-2022)
  • Table 96. France Genomics, by Technology USD Million (2017-2022)
  • Table 97. France Genomics, by Product USD Million (2017-2022)
  • Table 98. France Genomics, by End User USD Million (2017-2022)
  • Table 99. Italy Genomics, by Application USD Million (2017-2022)
  • Table 100. Italy Genomics, by Services USD Million (2017-2022)
  • Table 101. Italy Genomics, by Technology USD Million (2017-2022)
  • Table 102. Italy Genomics, by Product USD Million (2017-2022)
  • Table 103. Italy Genomics, by End User USD Million (2017-2022)
  • Table 104. United Kingdom Genomics, by Application USD Million (2017-2022)
  • Table 105. United Kingdom Genomics, by Services USD Million (2017-2022)
  • Table 106. United Kingdom Genomics, by Technology USD Million (2017-2022)
  • Table 107. United Kingdom Genomics, by Product USD Million (2017-2022)
  • Table 108. United Kingdom Genomics, by End User USD Million (2017-2022)
  • Table 109. Netherlands Genomics, by Application USD Million (2017-2022)
  • Table 110. Netherlands Genomics, by Services USD Million (2017-2022)
  • Table 111. Netherlands Genomics, by Technology USD Million (2017-2022)
  • Table 112. Netherlands Genomics, by Product USD Million (2017-2022)
  • Table 113. Netherlands Genomics, by End User USD Million (2017-2022)
  • Table 114. Rest of Europe Genomics, by Application USD Million (2017-2022)
  • Table 115. Rest of Europe Genomics, by Services USD Million (2017-2022)
  • Table 116. Rest of Europe Genomics, by Technology USD Million (2017-2022)
  • Table 117. Rest of Europe Genomics, by Product USD Million (2017-2022)
  • Table 118. Rest of Europe Genomics, by End User USD Million (2017-2022)
  • Table 119. MEA Genomics, by Country USD Million (2017-2022)
  • Table 120. MEA Genomics, by Application USD Million (2017-2022)
  • Table 121. MEA Genomics, by Services USD Million (2017-2022)
  • Table 122. MEA Genomics, by Technology USD Million (2017-2022)
  • Table 123. MEA Genomics, by Product USD Million (2017-2022)
  • Table 124. MEA Genomics, by End User USD Million (2017-2022)
  • Table 125. Middle East Genomics, by Application USD Million (2017-2022)
  • Table 126. Middle East Genomics, by Services USD Million (2017-2022)
  • Table 127. Middle East Genomics, by Technology USD Million (2017-2022)
  • Table 128. Middle East Genomics, by Product USD Million (2017-2022)
  • Table 129. Middle East Genomics, by End User USD Million (2017-2022)
  • Table 130. Africa Genomics, by Application USD Million (2017-2022)
  • Table 131. Africa Genomics, by Services USD Million (2017-2022)
  • Table 132. Africa Genomics, by Technology USD Million (2017-2022)
  • Table 133. Africa Genomics, by Product USD Million (2017-2022)
  • Table 134. Africa Genomics, by End User USD Million (2017-2022)
  • Table 135. North America Genomics, by Country USD Million (2017-2022)
  • Table 136. North America Genomics, by Application USD Million (2017-2022)
  • Table 137. North America Genomics, by Services USD Million (2017-2022)
  • Table 138. North America Genomics, by Technology USD Million (2017-2022)
  • Table 139. North America Genomics, by Product USD Million (2017-2022)
  • Table 140. North America Genomics, by End User USD Million (2017-2022)
  • Table 141. United States Genomics, by Application USD Million (2017-2022)
  • Table 142. United States Genomics, by Services USD Million (2017-2022)
  • Table 143. United States Genomics, by Technology USD Million (2017-2022)
  • Table 144. United States Genomics, by Product USD Million (2017-2022)
  • Table 145. United States Genomics, by End User USD Million (2017-2022)
  • Table 146. Canada Genomics, by Application USD Million (2017-2022)
  • Table 147. Canada Genomics, by Services USD Million (2017-2022)
  • Table 148. Canada Genomics, by Technology USD Million (2017-2022)
  • Table 149. Canada Genomics, by Product USD Million (2017-2022)
  • Table 150. Canada Genomics, by End User USD Million (2017-2022)
  • Table 151. Mexico Genomics, by Application USD Million (2017-2022)
  • Table 152. Mexico Genomics, by Services USD Million (2017-2022)
  • Table 153. Mexico Genomics, by Technology USD Million (2017-2022)
  • Table 154. Mexico Genomics, by Product USD Million (2017-2022)
  • Table 155. Mexico Genomics, by End User USD Million (2017-2022)
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Genomics: by Application(USD Million)
  • Table 168. Genomics Drug Discovery and Development , by Region USD Million (2023-2028)
  • Table 169. Genomics Diagnostics , by Region USD Million (2023-2028)
  • Table 170. Genomics Others , by Region USD Million (2023-2028)
  • Table 171. Genomics: by Services(USD Million)
  • Table 172. Genomics NGS-based Services , by Region USD Million (2023-2028)
  • Table 173. Genomics Core Genomics Services , by Region USD Million (2023-2028)
  • Table 174. Genomics Biomarket Translation Services , by Region USD Million (2023-2028)
  • Table 175. Genomics Computational Services , by Region USD Million (2023-2028)
  • Table 176. Genomics Others , by Region USD Million (2023-2028)
  • Table 177. Genomics: by Technology(USD Million)
  • Table 178. Genomics Sequencing , by Region USD Million (2023-2028)
  • Table 179. Genomics Microarray , by Region USD Million (2023-2028)
  • Table 180. Genomics PCR , by Region USD Million (2023-2028)
  • Table 181. Genomics Others , by Region USD Million (2023-2028)
  • Table 182. Genomics: by End User(USD Million)
  • Table 183. Genomics Hospitals , by Region USD Million (2023-2028)
  • Table 184. Genomics Academic and Research Institutes , by Region USD Million (2023-2028)
  • Table 185. Genomics Pharmaceutical and Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 186. Genomics Others , by Region USD Million (2023-2028)
  • Table 187. South America Genomics, by Country USD Million (2023-2028)
  • Table 188. South America Genomics, by Application USD Million (2023-2028)
  • Table 189. South America Genomics, by Services USD Million (2023-2028)
  • Table 190. South America Genomics, by Technology USD Million (2023-2028)
  • Table 191. South America Genomics, by Product USD Million (2023-2028)
  • Table 192. South America Genomics, by End User USD Million (2023-2028)
  • Table 193. Brazil Genomics, by Application USD Million (2023-2028)
  • Table 194. Brazil Genomics, by Services USD Million (2023-2028)
  • Table 195. Brazil Genomics, by Technology USD Million (2023-2028)
  • Table 196. Brazil Genomics, by Product USD Million (2023-2028)
  • Table 197. Brazil Genomics, by End User USD Million (2023-2028)
  • Table 198. Argentina Genomics, by Application USD Million (2023-2028)
  • Table 199. Argentina Genomics, by Services USD Million (2023-2028)
  • Table 200. Argentina Genomics, by Technology USD Million (2023-2028)
  • Table 201. Argentina Genomics, by Product USD Million (2023-2028)
  • Table 202. Argentina Genomics, by End User USD Million (2023-2028)
  • Table 203. Rest of South America Genomics, by Application USD Million (2023-2028)
  • Table 204. Rest of South America Genomics, by Services USD Million (2023-2028)
  • Table 205. Rest of South America Genomics, by Technology USD Million (2023-2028)
  • Table 206. Rest of South America Genomics, by Product USD Million (2023-2028)
  • Table 207. Rest of South America Genomics, by End User USD Million (2023-2028)
  • Table 208. Asia Pacific Genomics, by Country USD Million (2023-2028)
  • Table 209. Asia Pacific Genomics, by Application USD Million (2023-2028)
  • Table 210. Asia Pacific Genomics, by Services USD Million (2023-2028)
  • Table 211. Asia Pacific Genomics, by Technology USD Million (2023-2028)
  • Table 212. Asia Pacific Genomics, by Product USD Million (2023-2028)
  • Table 213. Asia Pacific Genomics, by End User USD Million (2023-2028)
  • Table 214. China Genomics, by Application USD Million (2023-2028)
  • Table 215. China Genomics, by Services USD Million (2023-2028)
  • Table 216. China Genomics, by Technology USD Million (2023-2028)
  • Table 217. China Genomics, by Product USD Million (2023-2028)
  • Table 218. China Genomics, by End User USD Million (2023-2028)
  • Table 219. Japan Genomics, by Application USD Million (2023-2028)
  • Table 220. Japan Genomics, by Services USD Million (2023-2028)
  • Table 221. Japan Genomics, by Technology USD Million (2023-2028)
  • Table 222. Japan Genomics, by Product USD Million (2023-2028)
  • Table 223. Japan Genomics, by End User USD Million (2023-2028)
  • Table 224. India Genomics, by Application USD Million (2023-2028)
  • Table 225. India Genomics, by Services USD Million (2023-2028)
  • Table 226. India Genomics, by Technology USD Million (2023-2028)
  • Table 227. India Genomics, by Product USD Million (2023-2028)
  • Table 228. India Genomics, by End User USD Million (2023-2028)
  • Table 229. South Korea Genomics, by Application USD Million (2023-2028)
  • Table 230. South Korea Genomics, by Services USD Million (2023-2028)
  • Table 231. South Korea Genomics, by Technology USD Million (2023-2028)
  • Table 232. South Korea Genomics, by Product USD Million (2023-2028)
  • Table 233. South Korea Genomics, by End User USD Million (2023-2028)
  • Table 234. Taiwan Genomics, by Application USD Million (2023-2028)
  • Table 235. Taiwan Genomics, by Services USD Million (2023-2028)
  • Table 236. Taiwan Genomics, by Technology USD Million (2023-2028)
  • Table 237. Taiwan Genomics, by Product USD Million (2023-2028)
  • Table 238. Taiwan Genomics, by End User USD Million (2023-2028)
  • Table 239. Australia Genomics, by Application USD Million (2023-2028)
  • Table 240. Australia Genomics, by Services USD Million (2023-2028)
  • Table 241. Australia Genomics, by Technology USD Million (2023-2028)
  • Table 242. Australia Genomics, by Product USD Million (2023-2028)
  • Table 243. Australia Genomics, by End User USD Million (2023-2028)
  • Table 244. Rest of Asia-Pacific Genomics, by Application USD Million (2023-2028)
  • Table 245. Rest of Asia-Pacific Genomics, by Services USD Million (2023-2028)
  • Table 246. Rest of Asia-Pacific Genomics, by Technology USD Million (2023-2028)
  • Table 247. Rest of Asia-Pacific Genomics, by Product USD Million (2023-2028)
  • Table 248. Rest of Asia-Pacific Genomics, by End User USD Million (2023-2028)
  • Table 249. Europe Genomics, by Country USD Million (2023-2028)
  • Table 250. Europe Genomics, by Application USD Million (2023-2028)
  • Table 251. Europe Genomics, by Services USD Million (2023-2028)
  • Table 252. Europe Genomics, by Technology USD Million (2023-2028)
  • Table 253. Europe Genomics, by Product USD Million (2023-2028)
  • Table 254. Europe Genomics, by End User USD Million (2023-2028)
  • Table 255. Germany Genomics, by Application USD Million (2023-2028)
  • Table 256. Germany Genomics, by Services USD Million (2023-2028)
  • Table 257. Germany Genomics, by Technology USD Million (2023-2028)
  • Table 258. Germany Genomics, by Product USD Million (2023-2028)
  • Table 259. Germany Genomics, by End User USD Million (2023-2028)
  • Table 260. France Genomics, by Application USD Million (2023-2028)
  • Table 261. France Genomics, by Services USD Million (2023-2028)
  • Table 262. France Genomics, by Technology USD Million (2023-2028)
  • Table 263. France Genomics, by Product USD Million (2023-2028)
  • Table 264. France Genomics, by End User USD Million (2023-2028)
  • Table 265. Italy Genomics, by Application USD Million (2023-2028)
  • Table 266. Italy Genomics, by Services USD Million (2023-2028)
  • Table 267. Italy Genomics, by Technology USD Million (2023-2028)
  • Table 268. Italy Genomics, by Product USD Million (2023-2028)
  • Table 269. Italy Genomics, by End User USD Million (2023-2028)
  • Table 270. United Kingdom Genomics, by Application USD Million (2023-2028)
  • Table 271. United Kingdom Genomics, by Services USD Million (2023-2028)
  • Table 272. United Kingdom Genomics, by Technology USD Million (2023-2028)
  • Table 273. United Kingdom Genomics, by Product USD Million (2023-2028)
  • Table 274. United Kingdom Genomics, by End User USD Million (2023-2028)
  • Table 275. Netherlands Genomics, by Application USD Million (2023-2028)
  • Table 276. Netherlands Genomics, by Services USD Million (2023-2028)
  • Table 277. Netherlands Genomics, by Technology USD Million (2023-2028)
  • Table 278. Netherlands Genomics, by Product USD Million (2023-2028)
  • Table 279. Netherlands Genomics, by End User USD Million (2023-2028)
  • Table 280. Rest of Europe Genomics, by Application USD Million (2023-2028)
  • Table 281. Rest of Europe Genomics, by Services USD Million (2023-2028)
  • Table 282. Rest of Europe Genomics, by Technology USD Million (2023-2028)
  • Table 283. Rest of Europe Genomics, by Product USD Million (2023-2028)
  • Table 284. Rest of Europe Genomics, by End User USD Million (2023-2028)
  • Table 285. MEA Genomics, by Country USD Million (2023-2028)
  • Table 286. MEA Genomics, by Application USD Million (2023-2028)
  • Table 287. MEA Genomics, by Services USD Million (2023-2028)
  • Table 288. MEA Genomics, by Technology USD Million (2023-2028)
  • Table 289. MEA Genomics, by Product USD Million (2023-2028)
  • Table 290. MEA Genomics, by End User USD Million (2023-2028)
  • Table 291. Middle East Genomics, by Application USD Million (2023-2028)
  • Table 292. Middle East Genomics, by Services USD Million (2023-2028)
  • Table 293. Middle East Genomics, by Technology USD Million (2023-2028)
  • Table 294. Middle East Genomics, by Product USD Million (2023-2028)
  • Table 295. Middle East Genomics, by End User USD Million (2023-2028)
  • Table 296. Africa Genomics, by Application USD Million (2023-2028)
  • Table 297. Africa Genomics, by Services USD Million (2023-2028)
  • Table 298. Africa Genomics, by Technology USD Million (2023-2028)
  • Table 299. Africa Genomics, by Product USD Million (2023-2028)
  • Table 300. Africa Genomics, by End User USD Million (2023-2028)
  • Table 301. North America Genomics, by Country USD Million (2023-2028)
  • Table 302. North America Genomics, by Application USD Million (2023-2028)
  • Table 303. North America Genomics, by Services USD Million (2023-2028)
  • Table 304. North America Genomics, by Technology USD Million (2023-2028)
  • Table 305. North America Genomics, by Product USD Million (2023-2028)
  • Table 306. North America Genomics, by End User USD Million (2023-2028)
  • Table 307. United States Genomics, by Application USD Million (2023-2028)
  • Table 308. United States Genomics, by Services USD Million (2023-2028)
  • Table 309. United States Genomics, by Technology USD Million (2023-2028)
  • Table 310. United States Genomics, by Product USD Million (2023-2028)
  • Table 311. United States Genomics, by End User USD Million (2023-2028)
  • Table 312. Canada Genomics, by Application USD Million (2023-2028)
  • Table 313. Canada Genomics, by Services USD Million (2023-2028)
  • Table 314. Canada Genomics, by Technology USD Million (2023-2028)
  • Table 315. Canada Genomics, by Product USD Million (2023-2028)
  • Table 316. Canada Genomics, by End User USD Million (2023-2028)
  • Table 317. Mexico Genomics, by Application USD Million (2023-2028)
  • Table 318. Mexico Genomics, by Services USD Million (2023-2028)
  • Table 319. Mexico Genomics, by Technology USD Million (2023-2028)
  • Table 320. Mexico Genomics, by Product USD Million (2023-2028)
  • Table 321. Mexico Genomics, by End User USD Million (2023-2028)
  • Table 322. Research Programs/Design for This Report
  • Table 323. Key Data Information from Secondary Sources
  • Table 324. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Genomics: by Application USD Million (2017-2022)
  • Figure 5. Global Genomics: by Services USD Million (2017-2022)
  • Figure 6. Global Genomics: by Technology USD Million (2017-2022)
  • Figure 7. Global Genomics: by End User USD Million (2017-2022)
  • Figure 8. South America Genomics Share (%), by Country
  • Figure 9. Asia Pacific Genomics Share (%), by Country
  • Figure 10. Europe Genomics Share (%), by Country
  • Figure 11. MEA Genomics Share (%), by Country
  • Figure 12. North America Genomics Share (%), by Country
  • Figure 13. Global Genomics share by Players 2022 (%)
  • Figure 14. Global Genomics share by Players (Top 3) 2022(%)
  • Figure 15. Global Genomics share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 19. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Illumina, Inc. (United States) Revenue: by Geography 2022
  • Figure 21. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. QIAGEN N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 23. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Agilent Technologies, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Eurofins Scientific (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Eurofins Scientific (Germany) Revenue: by Geography 2022
  • Figure 27. BGI Genomics (China) Revenue, Net Income and Gross profit
  • Figure 28. BGI Genomics (China) Revenue: by Geography 2022
  • Figure 29. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 30. GE Healthcare (United States) Revenue: by Geography 2022
  • Figure 31. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 35. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Myriad Genetics (United States) Revenue, Net Income and Gross profit
  • Figure 38. Myriad Genetics (United States) Revenue: by Geography 2022
  • Figure 39. Global Genomics: by Application USD Million (2023-2028)
  • Figure 40. Global Genomics: by Services USD Million (2023-2028)
  • Figure 41. Global Genomics: by Technology USD Million (2023-2028)
  • Figure 42. Global Genomics: by End User USD Million (2023-2028)
  • Figure 43. South America Genomics Share (%), by Country
  • Figure 44. Asia Pacific Genomics Share (%), by Country
  • Figure 45. Europe Genomics Share (%), by Country
  • Figure 46. MEA Genomics Share (%), by Country
  • Figure 47. North America Genomics Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Illumina, Inc. (United States)
  • QIAGEN N.V. (Netherlands)
  • Agilent Technologies, Inc. (United States)
  • Eurofins Scientific (Germany)
  • BGI Genomics (China)
  • GE Healthcare (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Pacific Biosciences of California, Inc. (United States)
  • Myriad Genetics (United States)
Select User Access Type

Key Highlights of Report


Oct 2023 219 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Genomics Quantitative research analysis
Global Genomics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Genomics market are Thermo Fisher Scientific, Inc. (United States), Illumina, Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Eurofins Scientific (Germany), BGI Genomics (China), GE Healthcare (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (United States) and Myriad Genetics (United States), to name a few.
North America is dominating the Genomics Market.
"Problem Regarding Secure Storage of Large Volumes of Sequenced Data as well as Dearth of Trained Professionals" is seen as one of the major challenges by many Industry Players of Genomics Market
The Genomics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Genomics market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Genomics Report?

Have a Query? Click Here

Other Related Reports

Medicinal Fungi Comprehensive Study by Type (Micafungin, Mycophenolate, Rosuvastatin, Others), Application (Household, Commercial, Industrial), Form (Powder, Whole, Slices, Extract), End-use (Antioxi...
$ 3350
Chrysin Extract Comprehensive Study by Application (Food Additive, Cosmetics and Personal Care, Dietary Supplements, Pharmaceuticals, Others), Form (Liquid, Powder, Capsules), Distribution Channel (O...
$ 3450
Nano-drug Comprehensive Study by Type (Nanoparticles (Metal & Metal Oxide Nanoparticles, Liposomes, Polymers & polymer-drug conjugates, Hydrogel nanoparticles, Dendrimers, Inorganic nanoparticles), N...
$ 3750
Mice Model Comprehensive Study by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice), Application (Cancer Research, Inflammation...
$ 3750
Protein Purification & Isolation Comprehensive Study by End Users (Hospitals and Diagnostic Centers, Contract Research Organization, Academic Medical Institutes, Pharmaceuticals & Biotechnology), Pro...
$ 3800
Biologics Safety Testing Comprehensive Study by Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Cell Line Authentication, Residual Host C...
$ 3750